CAN
NVO

Cetera Advisor Networks’s Novo Nordisk NVO Stock Holding History

Cetera Advisor Networks’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$21.9M Buy
170,897
+33,482
+24% +$3.99M 0.11% 198
2023
Q4 		$14.2M Buy
137,415
+8,822
+7% +$872K 0.08% 262
2023
Q3 		$11.7M Sell
128,593
-1,363
-1% -$120K 0.07% 279
2023
Q2 		$10.5M Buy
129,956
+37,314
+40% +$3.05M 0.07% 283
2023
Q1 		$7.37M Buy
92,642
+6,626
+8% +$470K 0.05% 352
2022
Q4 		$5.82M Buy
86,016
+33,168
+63% +$1.94M 0.05% 408
2022
Q3 		$2.63M Buy
52,848
+12,636
+31% +$677K 0.03% 499
2022
Q2 		$2.24M Sell
40,212
-228
-0.6% -$12.7K 0.03% 549
2022
Q1 		$2.25M Buy
40,440
+7,506
+23% +$385K 0.03% 577
2021
Q4 		$1.84M Sell
32,934
-488
-1% -$26.4K 0.02% 628
2021
Q3 		$1.6M Buy
33,422
+1,182
+4% +$57.1K 0.02% 634
2021
Q2 		$1.35M Buy
32,240
+14,608
+83% +$566K 0.02% 686
2021
Q1 		$594K Buy
17,632
+3,464
+24% +$123K 0.01% 793
2020
Q4 		$495K Sell
14,168
-668
-5% -$23.1K 0.01% 798
2020
Q3 		$515K Sell
14,836
-3,458
-19% -$115K 0.01% 707
2020
Q2 		$599K Buy
18,294
+3,084
+20% +$98.4K 0.02% 624
2020
Q1 		$458K Buy
15,210
+1,714
+13% +$51K 0.02% 637
2019
Q4 		$391K Sell
13,496
-994
-7% -$27.5K 0.01% 837
2019
Q3 		$374K Sell
14,490
-436
-3% -$11K 0.01% 823
2019
Q2 		$381K Buy
14,926
+2,724
+22% +$67.3K 0.01% 794
2019
Q1 		$320K Buy
12,202
+524
+4% +$12.9K 0.01% 841
2018
Q4 		$269K Sell
11,678
-892
-7% -$19.8K 0.01% 809
2018
Q3 		$296K Sell
12,570
-6,916
-35% -$169K 0.01% 879
2018
Q2 		$451K Sell
19,486
-1,740
-8% -$41.4K 0.02% 509
2018
Q1 		$524K Sell
21,226
-2,760
-12% -$72.5K 0.02% 486
2017
Q4 		$644K Sell
23,986
-178
-0.7% -$4.53K 0.03% 485
2017
Q3 		$583K Buy
24,164
+4,302
+22% +$97.2K 0.03% 487
2017
Q2 		$424K Sell
19,862
-1,200
-6% -$24.2K 0.02% 570
2017
Q1 		$360K Buy
21,062
+1,540
+8% +$26.8K 0.02% 630
2016
Q4 		$351K Sell
19,522
-6,138
-24% -$111K 0.02% 600
2016
Q3 		$534K Buy
25,660
+682
+3% +$16.9K 0.02% 566
2016
Q2 		$674K Sell
24,978
-1,450
-5% -$39.8K 0.04% 369
2016
Q1 		$716K Buy
26,428
+54
+0.2% +$1.45K 0.04% 353
2015
Q4 		$771K Buy
26,374
+728
+3% +$20.1K 0.05% 332
2015
Q3 		$696K Sell
25,646
-24,116
-48% -$683K 0.05% 341
2015
Q2 		$1.32M Hold
49,762
– – 0.08% 239
2015
Q1 		$1.32M Sell
49,762
-13,732
-22% -$316K 0.08% 239
2014
Q4 		$1.34M Buy
63,494
+3,170
+5% +$70.8K 0.1% 216
2014
Q3 		$1.44M Sell
60,324
-4,876
-7% -$112K 0.1% 212
2014
Q2 		$1.5M Buy
65,200
+1,552
+2% +$34.3K 0.1% 222
2014
Q1 		$1.45M Buy
63,648
+16,288
+34% +$347K 0.1% 207
2013
Q4 		$873K Buy
47,360
+3,820
+9% +$66.6K 0.07% 293
2013
Q3 		$735K Buy
43,540
+28,290
+186% +$476K 0.06% 288
2013
Q2 		$237K Buy
+15,250
New +$254K 0.02% 501

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cetera Advisor Networks's NVO Position: Q1 2024 in Review

Cetera Advisor Networks increased its Novo Nordisk (NVO) stake by 24% in Q1 2024, buying an estimated $3.99M and bringing the position to 170,897 shares worth $21.9M. The position accounts for 0.11% of the portfolio, ranked #198.

Cetera Advisor Networks first reported a position in NVO in Q2 2013 and has held it in 44 quarters since. 1,745 funds tracked by Wall St. Rank hold NVO as of Q1 2024.

  • Cetera Advisor Networks held 170,897 shares of Novo Nordisk worth $21.9M as of Q1 2024.
  • Cetera Advisor Networks bought 33,482 Novo Nordisk shares in Q1 2024, an estimated $3.99M.
  • Novo Nordisk made up 0.11% of Cetera Advisor Networks's portfolio in Q1 2024, its #198 holding.
  • Cetera Advisor Networks first reported a position in Novo Nordisk in Q2 2013 and has held it in 44 quarters since.
  • 1,745 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.